Value Bridge — UNIVERSITY OF IOWA HOSP & CLINICS
Current $-185M → Target $-135M (+$49.7M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-185.2M
Current EBITDA
$-135.5M
Target EBITDA
+$49.7M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$11.3M
Payer Mix Optimization
$27.0M
Cost to Collect Reduction
$9.0M
Clean Claim Improvement
$6.8M
Volume & Rate Growth
$45.0M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-185M to $-135M. The highest-impact lever is Volume & Rate Growth at $18.0M probability-weighted.
IC talking point: "We see $50M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $547M in equity value creation."